Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N
Published October 29, 2025 · Recall initiated: October 9, 2025
Summary
FDA records drug Class II recall D-0098-2026, published October 29, 2025 and initiated October 9, 2025. Recalling firm: ibspot; Status: Ongoing; Reported quantity: 3 boxes; Lot: none. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ibspot
- Distributor
- WY and VA
- Lot
- none
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOpdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial,October 29, 2025
- FDAJumbo Meat Ball Sub; Net Weight: 8.9oz; Product Code: Fresh Thru 10-15-25, 10/16/2025, 10/20/2025 In clearOctober 29, 2025
- FDANiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: LannettOctober 29, 2025
- FDAFloria Dried Apricots, 200 Gram packages, 40 packages per case .October 29, 2025
- FDAZICAM" MEDICATED FRUIT DROPS ELDERBERRY FLAVOR, 25-drops per bottle, Distributed by: Church & Dwight Co., Inc.October 29, 2025
- FDASmoked Mozzarella Penne Salad, bulk, UPC 256616000000October 29, 2025
Questions about this recall
Was Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N recalled?
Yes. FDA published recall D-0098-2026 on October 29, 2025. Reported hazard: Marketed Without an Approved NDA/ANDA
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail